These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 34586012)

  • 21. The role of MUC2 mucin in intestinal homeostasis and the impact of dietary components on MUC2 expression.
    Liu Y; Yu X; Zhao J; Zhang H; Zhai Q; Chen W
    Int J Biol Macromol; 2020 Dec; 164():884-891. PubMed ID: 32707285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal glycan degradation of the host by the gut microbiota.
    Bell A; Juge N
    Glycobiology; 2021 Jun; 31(6):691-696. PubMed ID: 33043970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.
    Cristofori F; Dargenio VN; Dargenio C; Miniello VL; Barone M; Francavilla R
    Front Immunol; 2021; 12():578386. PubMed ID: 33717063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental models to study intestinal microbes-mucus interactions in health and disease.
    Etienne-Mesmin L; Chassaing B; Desvaux M; De Paepe K; Gresse R; Sauvaitre T; Forano E; de Wiele TV; Schüller S; Juge N; Blanquet-Diot S
    FEMS Microbiol Rev; 2019 Sep; 43(5):457-489. PubMed ID: 31162610
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Gu Y; Qin X; Zhou G; Wang C; Mu C; Liu X; Zhong W; Xu X; Wang B; Jiang K; Liu J; Cao H
    Food Funct; 2022 Nov; 13(23):12144-12155. PubMed ID: 36326009
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of mucin
    Fekete E; Buret AG
    Am J Physiol Gastrointest Liver Physiol; 2023 Jun; 324(6):G452-G465. PubMed ID: 37070751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucin glycans and their degradation by gut microbiota.
    Yamaguchi M; Yamamoto K
    Glycoconj J; 2023 Aug; 40(4):493-512. PubMed ID: 37318672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of the Importance of Biotics in Gut Barrier Integrity.
    Kocot AM; Jarocka-Cyrta E; Drabińska N
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome?
    Kapoor B; Gulati M; Gupta R; Singla RK
    Autoimmun Rev; 2023 May; 22(5):103313. PubMed ID: 36918089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis.
    Fang J; Wang H; Zhou Y; Zhang H; Zhou H; Zhang X
    Exp Mol Med; 2021 May; 53(5):772-787. PubMed ID: 34002011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal goblet cells and mucins in health and disease: recent insights and progress.
    Kim YS; Ho SB
    Curr Gastroenterol Rep; 2010 Oct; 12(5):319-30. PubMed ID: 20703838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of gut mucosal biofilms.
    Kleessen B; Blaut M
    Br J Nutr; 2005 Apr; 93 Suppl 1():S35-40. PubMed ID: 15877893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive values of colon microbiota in the treatment response to colorectal cancer.
    Galan-Ros J; Ramos-Arenas V; Conesa-Zamora P
    Pharmacogenomics; 2020 Sep; 21(14):1045-1059. PubMed ID: 32896201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone Deacetylase Modifications by Probiotics in Colorectal Cancer.
    Salek Farrokhi A; Mohammadlou M; Abdollahi M; Eslami M; Yousefi B
    J Gastrointest Cancer; 2020 Sep; 51(3):754-764. PubMed ID: 31808058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbe-based management for colorectal cancer.
    Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
    Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Functional Properties of Intestinal Mucus Layer in Poultry.
    Duangnumsawang Y; Zentek J; Goodarzi Boroojeni F
    Front Immunol; 2021; 12():745849. PubMed ID: 34671361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites.
    Yang J; Wei H; Zhou Y; Szeto CH; Li C; Lin Y; Coker OO; Lau HCH; Chan AWH; Sung JJY; Yu J
    Gastroenterology; 2022 Jan; 162(1):135-149.e2. PubMed ID: 34461052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotics, prebiotics and amelioration of diseases.
    Tsai YL; Lin TL; Chang CJ; Wu TR; Lai WF; Lu CC; Lai HC
    J Biomed Sci; 2019 Jan; 26(1):3. PubMed ID: 30609922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interindividual variability in gut microbiota and host response to dietary interventions.
    Healey GR; Murphy R; Brough L; Butts CA; Coad J
    Nutr Rev; 2017 Dec; 75(12):1059-1080. PubMed ID: 29190368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulation aspects of gut microbiome-related interventional strategies in colorectal cancer.
    Cheraghpour M; Fatemi N; Shadnoush M; Talebi G; Tierling S; Bermúdez-Humarán LG
    Med Oncol; 2024 Aug; 41(9):231. PubMed ID: 39162936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.